REATA PHARMACEUTICALS INC Annual Income Tax Expense (Benefit) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Reata Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2022.
  • Reata Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $0.000.
  • Reata Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was -$55K, a 122% decline year-over-year.
  • Reata Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was -$25K, a 94.4% increase from 2021.
  • Reata Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$450K, a 98% increase from 2020.
  • Reata Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was -$22.5M, a 281188% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$25K +$425K +94.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 -$450K +$22M +98% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 -$22.5M* -$22.5M -281188% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $8K -$18K -69.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $26K +$23K +767% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $3K +$444K Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 -$441K -$1.59M -138% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1.15M -$1.83M -61.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
2014 $2.98M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.